🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial is studying the safety and efficacy of a personalized c...
Status
Recruiting
Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Start Date
2024-03-01
Trial ID
NCT07002203
Treatments Being Tested
In this study, the investigators provide a combined treatment of personaliz...
Status
Recruiting
Location
First Affiliated Hospital of Nanchang University
Start Date
2024-09-01
Trial ID
NCT06751914
Treatments Being Tested
This is an early phase I, single-arm, open-label clinical study designed to...
Status
Recruiting
Location
Biogenea Pharmaeuticals Ltd
Start Date
2026-02-02
Trial ID
NCT07328087
Treatments Being Tested
This phase I/II trial tests the safety and tolerability of an experimental ...
Status
Recruiting
Location
Mayo Clinic in Florida
Start Date
2022-03-31
Trial ID
NCT05269381
This clinical trial aims to evaluate the safety, immunogenicity, and prelim...
Status
Completed
Location
Vejthani Hospital
Start Date
2022-11-24
Trial ID
NCT06614140
Treatments Being Tested
This is a single institution, open-label, multi-arm, pilot study assessing ...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2018-10-31
Trial ID
NCT03422094
Treatments Being Tested
This is a phase 1 open-label study to evaluate the safety and immunogenicit...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2020-02-13
Trial ID
NCT03956056
Treatments Being Tested
Tumor lysate or carcinoembryonic antigen (CEA) derived DCs-based therapy is...
Status
Unknown
Location
Kaohsiung Medical University Hospital
Start Date
2023-06-01
Trial ID
NCT05767684
Treatments Being Tested
This is a phase 1 clinical trial to evaluate the safety, feasibility and im...
Status
Not Yet Recruiting
Location
Washington University School of Medicine
Start Date
2026-08-01
Trial ID
NCT07300475
Despite encouraging results of programmed cell death protein -1 (PD-1) immu...
Status
Unknown
Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Start Date
2022-01
Trial ID
NCT04998474
Treatments Being Tested